"Real-world" evaluation of
(18)F-Choline PET/CT
Biochemical recurrence
Castration-resistance
Prostate cancer
Staging
Journal
Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
08
10
2018
revised:
18
07
2019
accepted:
22
07
2019
pubmed:
27
8
2019
medline:
28
4
2021
entrez:
27
8
2019
Statut:
ppublish
Résumé
The role of This is a retrospective multicenter observational study including 265 consecutive men who underwent Median PSA level at the time of PET/CT was 4.19 ng/ml. The decision to perform PET/CT was made after multidisciplinary discussion in 29.8% of cases; most were prescribed by urologists (50.2% of cases). Three main indications were concerned: biochemical recurrence after local treatment (61.1%), initial staging (26.0%), or at the time of progression to castration-resistance (12.9%). Upon biochemical recurrence, Indications of
Identifiants
pubmed: 31447087
pii: S1078-1439(19)30294-7
doi: 10.1016/j.urolonc.2019.07.017
pii:
doi:
Substances chimiques
fluorocholine
6029HGL0QP
Choline
N91BDP6H0X
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2.e1-2.e9Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.